Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

Nanomedicine-driven tumor glucose metabolic reprogramming for enhanced cancer immunotherapy

Tumors exhibit abnormal glucose metabolism, consuming excessive glucose and excreting lactate, which constructs a tumor microenvironment that facilitates cancer progression and disrupts immunotherapeutic efficacy. Currently, tumor glucose metabolic dysregulation to reshape the immunosuppressive micr...

Full description

Saved in:
Bibliographic Details
Main Authors: Chenwei Jiang, Minglu Tang, Yun Su, Junjie Xie, Qi Shang, Mingmei Guo, Xiaoran An, Longfei Lin, Ruibin Wang, Qian Huang, Guangji Zhang, Hui Li, Feihu Wang
Format: Article
Language:English
Published: Elsevier 2025-06-01
Series:Acta Pharmaceutica Sinica B
Subjects:
Glucose metabolism
Glycolysis
Lactate
Cancer immunotherapy
Nanomedicine
Online Access:http://www.sciencedirect.com/science/article/pii/S2211383525002217
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://www.sciencedirect.com/science/article/pii/S2211383525002217

Similar Items